Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen

We have previously employed an intercellular spreading strategy using herpes simplex virus type 1 (HSV-1) VP22 protein to enhance DNA vaccine potency because DNA vaccines lack the intrinsic ability to amplify in cells. Recently, studies have demonstrated that the protein encoded by UL49 of Marek's d...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	J Virol
Principais autores:	Hung, Chien-Fu, He, Liangmei, Juang, Jeremy, Lin, Tzyy-Jye, Ling, Morris, Wu, T.-C.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 2002
נושאים:	Vaccines and Antiviral Agents
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC135982/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11861834/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.6.2676-2682.2002
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!